Expression of transferrin- and interleukin-2- receptors, and HLA-DR in human lung carcinoma
- 31 December 1991
- journal article
- Published by Elsevier in Experimental pathology
- Vol. 41 (1), 37-43
- https://doi.org/10.1016/s0232-1513(11)80044-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Retrospective and prospective tumor staging evaluating prognostic factors in operated bronchus carcinoma patientsCancer, 1987
- Determination of transferrin receptors on frozen sections of malignant B-cell lymphomas by immunofluorescence with a monoclonal antibodyCancer, 1986
- Heteroantibody duplexes target cells for lysis by cytotoxic T lymphocytes.Proceedings of the National Academy of Sciences, 1985
- Do monoclonal antibodies Tü15 and Tü67 detect heterogeneity of human transferrin receptor molecules?FEBS Letters, 1984
- Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: Limiting dilution analysis in peripheral blood and at the tumour siteInternational Journal of Cancer, 1982
- HLA Antigens and primary bronchial carcinomaCancer, 1982
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Serum-free cell culture: a unifying approachCell, 1980
- Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production.The Journal of Experimental Medicine, 1978
- HL‐A Antigens and Disease Statistical and Genetical ConsiderationsTissue Antigens, 1974